Recital 14, Decision_act (EU) 2025/1074

In forcesince 2 Jun 2025

The Union legislation on medicinal products contains provisions on the manufacturing of medicinal products, and in particular it establishes that the holder of a manufacturing authorisation is to comply with the principles and guidelines of good manufacturing practice, including with respect to the use of ethylene oxide for the sterilisation of certain medicinal products. Consequently, the intended uses of the applicant for ethylene oxide for the sterilisation of medicinal products and for the sterilisation of packaging intended for medicinal products, but without the product itself being present during sterilisation, whenever those activities are performed on a site holding a manufacturing authorisation in accordance with Article 40 of Directive 2001/83/EC and Article 88 of Regulation (EU) 2019/6, are covered by the scope of the Union legislation on medicinal products.